Skip to content

Indocyanine Green (ICG) Fluorescence Angiography for Quantitative Evaluation of Viability of Esophageal Substitute in Patients Undergoing Esophagectomy

Indocyanine Green (ICG) Fluorescence Angiography for Quantitative Evaluation of Viability of Esophageal Substitute in Patients Undergoing Esophagectomy - ICG Fluorescence Angiography for Evaluation of Viability of Esophageal Substitute

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017480
Enrollment
100
Registered
2015-05-09
Start date
2013-07-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

None listed

Sponsors

Kyushu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients undergoing esophageal reconstruction 2) patients who understand purpose of study and reveive informed consent 3) patents with 20 years old or older

Exclusion criteria

Exclusion criteria: 1) patients who have allergy to ICG 2) patients who are judged to be ineligible for subject by researcher

Design outcomes

Primary

MeasureTime frame
luminance assessed by ICG angiography, rate of anastomotic leakage

Secondary

MeasureTime frame
in-hospital days, kinds of complications, duration of complication healing

Countries

Japan

Contacts

Public ContactHiroshi Saeki

Kyushu University Department of Surgery and Science

h-saeki@surg2.med.kyushu-u.ac.jp092-642-5466

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026